title: Interaction of baboon anti-alpha-galactosyl antibody with pig tissues.
abstract: As barriers to xenotransplantation are surmounted, such as suppression of hyperacute rejection allowing improved graft survival, it becomes important to define longer-term host-xenograft interactions. To this end we have prepared in baboons high titer anti-alpha-Galactosyl (alphaGal) and anti-porcine aortic endothelial cell antibodies, similar to human natural xenoantibodies and reactive with epitopes of thyroglobulin, laminin, and heparan sulfate proteoglycans. When injected into pigs with a protocol similar to that used in the rat to show the nephritogenic potential of heterologous anti-laminin and anti-heparan sulfate proteoglycan antibodies, baboon immunoglobulins bound first to renal vascular endothelium, and later to interstitial cells, especially fibroblasts and macrophages, and to antigens in basement membranes and extracellular matrix, where they colocalized with laminin- and heparan sulfate proteoglycan-antibodies, and with bound Griffonia simplicifolia B4. A similar binding was observed in other organs. The pigs did not develop an acute complement-dependent inflammation, but rather chronic lesions of the basement membranes and the extracellular matrix. Incubation of renal fibroblasts with baboon anti-alpha-Galactosyl antibodies resulted in increased synthesis of transforming growth factor-beta and collagen, suggesting a possible basis for the fibrotic response. The results demonstrate that in this experimental model a consequence of alphaGal antibody interaction with porcine tissues, is immunoreactivity with alphaGal on matrix molecules and interstitial cells, priming mechanisms leading to fibrosis resembling that in chronic allograft rejection. The possibility that similar lesions may develop in long-surviving pig xenografts is discussed.
authors.affiliation: Department of Physiology, College of Physicians and Surgeons of Columbia University, New York, New York, USA.
authors.forename: S
authors.initials: S
authors.lastname: Maruyama
authors.forename: E
authors.initials: E
authors.lastname: Cantu
authors.forename: C
authors.initials: C
authors.lastname: DeMartino
authors.forename: C Y
authors.initials: CY
authors.lastname: Wang
authors.forename: J
authors.initials: J
authors.lastname: Chen
authors.forename: F
authors.initials: F
authors.lastname: Al-Mohanna
authors.forename: S M
authors.initials: SM
authors.lastname: Nakeeb
authors.forename: V
authors.initials: V
authors.lastname: D'Agati
authors.forename: B
authors.initials: B
authors.lastname: Pernis
authors.forename: U
authors.initials: U
authors.lastname: Galili
authors.forename: G
authors.initials: G
authors.lastname: Godman
authors.forename: D M
authors.initials: DM
authors.lastname: Stern
authors.forename: G
authors.initials: G
authors.lastname: Andres
mesh_terms: D000818:Animals; D000910:Antibodies, Heterophile / Q000276:immunology*; D000918:Antibody Specificity; D003429:Cross Reactions; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007150:Immunohistochemistry; D009928:Organ Specificity; D010215:Papio; D051381:Rats; D013045:Species Specificity; D013552:Swine; D014312:Trisaccharides / Q000276:immunology*
chemical_list: D000910:Antibodies, Heterophile; D014312:Trisaccharides; C076569:alpha-galactosyl epitope